Genome-wide screen of DNA methylation study in stage IIIa (N2) EGFR 19 deletion adenocarcinoma with erlotinib treatment.

e20067Background: Lung cancer is the leading cause of cancer related death in the world. The challenge of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (...